
Pharmaceutical Technology's In the Lab eNewsletter
The RK-1 continuous mixing processor from Readco Kurimoto is suited for testing formulations in continuous processing conditions.

Pharmaceutical Technology's In the Lab eNewsletter
The RK-1 continuous mixing processor from Readco Kurimoto is suited for testing formulations in continuous processing conditions.

Pharmaceutical Technology's In the Lab eNewsletter
Often, transferring an analytical method from R&D to quality control fails; success depends on determining where “the best” and “the most reliable” intersect.

Pharmaceutical Technology's In the Lab eNewsletter
LabVantage Solutions’ LabVantage 8.4 is the latest version of the company’s comprehensive laboratory information management system.

Pharmaceutical Technology's In the Lab eNewsletter
HORIBA’s new analytical microscope simultaneously performs elemental analysis and optical observation without destroying samples.

Pharmaceutical Technology's In the Lab eNewsletter
With higher volumes of analytical date being generated in pharmaceutical processing, digitization and platform integration are becoming increasingly important to implement.

Pharmaceutical Technology's In the Lab eNewsletter
The TSKgel FcR-IIIA-NPR HPLC column from Tosoh Bioscience is a FcRγ affinity chromatography analysis column suited for the analysis of immunoglobulin G glycoforms.

Pharmaceutical Technology's In the Lab eNewsletter
Valitacell and Solentim, have announced a collaboration aimed at the acceleration of discovery and development of biologic drugs and advanced cell therapies.

Pharmaceutical Technology's In the Lab eNewsletter
A multi-partner collaboration has been announced, which will target the acceleration of the development of automated microfluidic systems for rapid and high-throughput gene editing in mammalian cell lines.

Pharmaceutical Technology's In the Lab eNewsletter
The acquisition would strengthen Charles River’s contract research capabilities.

Pharmaceutical Technology's In the Lab eNewsletter
The multi-year agreement will give Novartis access to AbCellera’s expertise and state-of-the-art antibody discovery technology for up to ten clinically-relevant disease targets.

Pharmaceutical Technology's In the Lab eNewsletter
The companies will use a $4.4-million grant from the National Institute of Allergy and Infectious Diseases to discover sustainable alternatives to shark squalene to use as vaccine adjuvants.

Pharmaceutical Technology's In the Lab eNewsletter
The company will expand its global R&D footprint at its facility in Billerica, MA, with a $70-million investment.

Pharmaceutical Technology's In the Lab eNewsletter
The companies will develop a software-connected pipetting system for improved reproducibility and traceability in life-science laboratories.

Pharmaceutical Technology's In the Lab eNewsletter
A study funded by the National Institutes of Health has created a virtual library expected to expand the availability of “make-on-demand” molecules for drug discovery.

Pharmaceutical Technology's In the Lab eNewsletter
The RK-1 continuous mixing processor from Readco Kurimoto is suited for testing formulations in continuous processing conditions.